Professors Shana Kelley, Michael Sefton and Gang Zheng of the Institute of Biomaterials & Biomedical Engineering (IBBME) have received nearly $6.5 million in research funding from the Canadian

Developing products that will enable treatments for devastating health conditions such as heart disease, diabetes, cancer and spinal cord injuries is the focus of a major University of Toronto-hosted

The science fiction of melding man and machine has played out for decades onscreen, from The Six Million Dollar Man to The Terminator. But the bionic hybrid age may well be flickering to life –

In the midst of a blistering heat wave, most Torontonians aren’t thinking much about frigid temperatures, ice and winter spills. But in a special laboratory at the Toronto Rehabilitation Institute,

University of Toronto spinoff company Interface Biologics Inc. has announced the signing of an evaluation and exclusive license option agreement with Fresenius Medical Care, the world’s largest